Last week, victims of cervical spinal cord injuries got some much needed good news. The University of California in Irvine received $20 million from the California Institute for Regenerative Medicine. The money will be shared with research and innovation leader StemCells, Inc. based in Newark, California.
The fund will be used to focus on beginning clinical trials for humans with spinal cord injuries. StemCells' was the organization that discovered that transplanting human stem cells into rodents could restore their movement, even after a thoracic spinal cord injury.
Nearly 1.3 million Americans have to live with chronic complications from spinal cord injuries and about 147,000 are here in California alone. Patients require surgeries, steroids and rehabilitation for the rest of their lives.
The goal of this funding and research is to partially reverse some or even all of the effects of such a debilitating injury to improve the quality of life of Californians stricken with the need for constant medical care. They can be severely impaired with limited movement, sensations and reflexes. The hope is that this money will translate stem cell research into real-life clinical cures.
People suffering from paraplegia or quadriplegia as a result of a spinal cord injury need ongoing medical treatment. They will probably require in-home nursing care and extensive changes to their home. Our law firm works with life-care planners, medical specialists and vocational economists to develop a complete picture of the financial impact of the accident over the course of our client's lifetime. Learn more at our San Francisco Bay Area Spinal Cord Injury Lawyers web page.
Source: equities.com, "State Stem Cell Research Funding Agency Awards $20 Million to UCI, StemCells Inc.," July 27, 2012